Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 AK Wheatley, JA Juno, JJ Wang, KJ Selva, A Reynaldi, HX Tan, WS Lee, ... Nature communications 12 (1), 1162, 2021 | 376 | 2021 |
Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine Y Ju, WS Lee, EH Pilkington, HG Kelly, S Li, KJ Selva, KM Wragg, ... Acs Nano 16 (8), 11769-11780, 2022 | 212 | 2022 |
Systems serology detects functionally distinct coronavirus antibody features in children and elderly KJ Selva, CE Van De Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, ... Nature communications 12 (1), 2037, 2021 | 151 | 2021 |
Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19 S Tosif, MR Neeland, P Sutton, PV Licciardi, S Sarkar, KJ Selva, LAH Do, ... Nature communications 11 (1), 5703, 2020 | 115 | 2020 |
Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial KJ Chappell, FL Mordant, Z Li, DK Wijesundara, P Ellenberg, ... The Lancet Infectious Diseases 21 (10), 1383-1394, 2021 | 108 | 2021 |
Decay of Fc-dependent antibody functions after mild to moderate COVID-19 WS Lee, KJ Selva, SK Davis, BD Wines, A Reynaldi, R Esterbauer, ... Cell Reports Medicine 2 (6), 2021 | 81 | 2021 |
Serum IgA Fc effector functions in infectious disease and cancer SK Davis, KJ Selva, SJ Kent, AW Chung Immunology and cell biology 98 (4), 276-286, 2020 | 62 | 2020 |
Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domain AK Wheatley, P Pymm, R Esterbauer, MH Dietrich, WS Lee, D Drew, ... Cell Reports 37 (2), 2021 | 41 | 2021 |
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay E Lopez, ER Haycroft, A Adair, FL Mordant, M T O’Neill, P Pymm, ... JCI insight 6 (16), e150012, 2021 | 37 | 2021 |
Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection N Yawata, KJ Selva, YC Liu, KP Tan, AWL Lee, J Siak, W Lan, M Vania, ... Mucosal immunology 9 (1), 159-170, 2016 | 36 | 2016 |
Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features LC Rowntree, BY Chua, S Nicholson, M Koutsakos, L Hensen, C Douros, ... Clinical & translational immunology 10 (3), e1258, 2021 | 34 | 2021 |
The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus DSL Lim, N Yawata, KJ Selva, N Li, CY Tsai, LH Yeong, KH Liong, EE Ooi, ... The Journal of Immunology 193 (10), 5065-5075, 2014 | 32 | 2014 |
Distinct systems serology features in children, elderly and COVID patients KJ Selva, CE van de Sandt, MM Lemke, CY Lee, SK Shoffner, BY Chua, ... medRxiv, 2020.05. 11.20098459, 2020 | 28 | 2020 |
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severity W Zhang, BY Chua, KJ Selva, L Kedzierski, TM Ashhurst, ER Haycroft, ... Nature communications 13 (1), 2774, 2022 | 27 | 2022 |
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021; 12 (1): 1162 AK Wheatley, JA Juno, JJ Wang, KJ Selva, A Reynaldi, HX Tan, WS Lee, ... Epub 2021/02/21. https://doi. org/10.1038/s41467-021-21444-5 PMID: 33608522, 0 | 19 | |
Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma KJ Selva, SJ Kent, MS Parsons Aids 31 (3), 333-342, 2017 | 17 | 2017 |
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat. Commun. 12, 1162 AK Wheatley, JA Juno, JJ Wang, KJ Selva, A Reynaldi, HX Tan, WS Lee, ... | 15 | 2021 |
Insights into how SARS-CoV2 infection induces cytokine storms KJ Selva, AW Chung Trends in Immunology 43 (6), 417-419, 2022 | 14 | 2022 |
Tear antibodies to SARS‐CoV‐2: implications for transmission KJ Selva, SK Davis, ER Haycroft, WS Lee, E Lopez, A Reynaldi, ... Clinical & Translational Immunology 10 (11), e1354, 2021 | 14 | 2021 |
Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants ER Haycroft, SK Davis, P Ramanathan, E Lopez, RA Purcell, LL Tan, ... Medical Microbiology and Immunology 212 (4), 291-305, 2023 | 13 | 2023 |